潘金莲被吸乳揉到高潮的视频,久久99久久99精品免观看,在电影院里拨开内裤挺进,护士交换粗吟配乱大交动态图

Offter to Sell

Irbesartan

  • Post Date:

    Apr 05,2025
  • Expiry Date:

    Oct 02,2025
  • Detailed Description:

    Cas No. :138402-11-6 Specs:USP/EP
    Product IRBESARTAN
    CAS NO;138402-11-6
    Standard;USP
    MF;C25H28N6O
    MW;428.53


    Specification:
    Test Items Standard Result
    Description White crystalline powder Complies
    Solubility Slightly soluble in alcohol and in methylene chloride, practically insoluble in water Complies
    Identification:IR/HPLC Similar to standard Complies
    Water ≤0.5% 0.29%
    Residue on ignition ≤0.1% 0.04%
    Azide ≤0.001% Complies
    Heavy metal ≤0.002% Complies
    Related compounds
    Total compounds ≤0.5% 0.31%
    Releated compounds A ≤0.2% 0.05%
    Any other compound ≤0.1% 0.04%
    Assay 98.0%-102.0% (on anhydrous basis) 99.5%
    Residual solvents Ethanol≤5000ppm Not detected
    Toluene≤890ppm 75ppm
    Dichloromethane≤600ppm Not detected
    N,N-Dimethylformamide≤880ppm Not detected
    t-Butyl methyl ether≤5000ppm Not detected
    Conclusion It complies with all the requirements of USP35


    Patent Disclaimer:
    1. Products protected by valid patents are not offered for sale in jurisdictions where the sale of such products constitutes a patent infringement. The current list only reflects the products and technologies that are available, under development: note that some products may be developed or produced for internal and experimental uses with no commercal aim.
    2. Sales of products are limited to those allowed by Chapter VII PLPRC 63, the above includes Research and development quantities.
    3. R&D use in accordance with (1) 35 USC 271(e)+A13(1) in the U.S.; (2) Section 69.1 of Japanese Patent Law in Japan; (3) Section 11, No. 2 of the German Patent Act of 1981 in Germany; (iv) Section 60, Paragraph 5b of the U.K. Patents Act of 1977 in the U.K.; (4) Sections 55.2(1) and 55.2(6) and other common law exemptions of Canadian patent law; (5) Section 68B of the Patents Act of 1953 in New Zealand together with the amendment of same by the Statutes Amendment Bill of 2002; (6) such related legislation and/or case law as may be or become applicable in the aforementioned countries; and (7) such similar laws and rules as may apply in various other countries.
  • CAS Registry Number:

    138402-11-6
  • Synonyms:

    ;Irbesartan (GMP);3-butyl-2-[[4-[2-(2h-tetrazol-5-yl)phenyl]phenyl]methyl]-2,4-diazaspiro[4.4]non-3-en-1-one;2-BUTYL-3-[[2'-(1H-TETRAZOL-5-YL)[1,1'-BIPHENYL]-4-YL]METHYL]-1,3-DIAZASPIRO[4.4]NON-1-EN-4-ONE;BMS-186295;AVAPRO;APROVEL;SR-47436;2-butyl-3-{[2'-(2H-tetrazol-5-yl)biphenyl-4-yl]methyl}-1,3-diazaspiro[4.4]non-1-en-4-one;
  • Molecular Formula:

    C25H28N6O
  • Molecular Weight:

    428.5294
  • Molecular Structure:

    138402-11-6 Irbesartan
Inquiry
Home Suppliers Product CAS Gmall
主站蜘蛛池模板: 西乡县| 铅山县| 岗巴县| 怀化市| 芒康县| 太保市| 克东县| 贵溪市| 长汀县| 乐平市| 商河县| 如东县| 桃园县| 濮阳县| 肥乡县| 高密市| 济宁市| 台东县| 景宁| 泰兴市| 蚌埠市| 鹤山市| 渭南市| 青铜峡市| 吴堡县| 凤冈县| 华坪县| 富宁县| 开平市| 六安市| 鲜城| 英吉沙县| 荃湾区| 日喀则市| 绥江县| 夹江县| 云安县| 秭归县| 义马市| 萍乡市| 安西县|